Opportunity

SAM #36C24526Q0652

Contingency Hazardous Chemotherapy Compounding Services for VA Medical Center

Buyer

VA Network Contracting Office 5

Posted

July 30, 2026

Respond By

August 14, 2026

Identifier

36C24526Q0652

NAICS

325412, 621610

This opportunity is for contingency hazardous chemotherapy compounding services to support the Louis A. Johnson VA Medical Center in Clarksburg, West Virginia, ensuring uninterrupted patient care if the facility's IV pharmacy room is unavailable. - Government Buyer: - Department of Veterans Affairs, VA Maryland Health Care System - Office: Contracting Officer (19ACQ) - Services Requested: - On-demand, patient-specific hazardous chemotherapy compounding - Includes aseptic compounding, chemotherapy drug supply, ancillary supplies (CSTDs, tubing, bags), and shipping - All services must comply with FDA 503A and USP 797/800 standards - Products/Line Items: - Compounded Dose Labor Fee (per patient order) - Chemotherapy Drug Supply (billed per actual medication used) - Ancillary Supplies (closed system transfer devices, tubing, bags, etc.) - Shipping & Delivery (including cold chain transport) - Contract Structure: - Fixed price, 5-year Indefinite Delivery Indefinite Quantity (IDIQ) contract - Base year plus four option years - Minimum guarantee: $300; contract ceiling: $349,000 - Unique Requirements: - Contractor must provide all compounding and delivery services on a contingency basis if the medical center's IV room is non-operational - Adherence to strict regulatory and safety standards is mandatory - No specific OEMs or named vendors are identified in the solicitation

Description

Fixed Price 5-year Indefinite Delivery Indefinite Quantity (IDIQ) solicitation for contingency hazardous chemotherapy compounding services in the event the Louis A. Johnson VA Medical Center (LAJVAMC), Inpatient Pharmacy intravenous (IV) room becomes non-operational. Additional Links:Home Page

View original listing